Komori
Governance4151Kyowa Kirin Co.,Ltd.Pharmaceuticals

Matters Concerning Controlling Shareholders

Reported on the relationship in which Kirin Holdings Company,Limited is the parent company, transactions with the parent company, and measures to protect minority shareholders. The company has established a Nomination and Compensation Advisory Committee with a majority of independent outside directors, as well as a committee to oversee conflicts of interest.

Worth reading
100Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
198175
¥ million (average balance of loans to the parent company during the period)
Wording
Conditional
How definitive the wording is.

Governance structure

Controlling shareholder
Kirin Holdings Company,Limited55.22%Voting rights

parent company; voting rights ownership ratio: 55.22%

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Committee1
Nomination and Compensation Advisory Committee (a majority of independent outside directors); Group Company Intercompany Transaction Conflicts of Interest Oversight Committee
Percentage of outside members composed entirely of independent outside directors; 100% outside members
Governance structure
ItemDetails
CommitteeNomination and Compensation Advisory Committee (a majority of independent outside directors); Group Company Intercompany Transaction Conflicts of Interest Oversight Committee (composed entirely of independent outside directors; 100% outside members)
Controlling shareholderKirin Holdings Company,Limited (parent company; voting rights ownership ratio: 55.22%)
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To leverage the management resources, expertise and know-how of Kirin Holdings Company,Limited, thereby establishing a business foundation and creating synergies with the health science business. For loans to the parent company, interest rates are determined reasonably after taking into account market interest rates based on the lending period.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | Kyowa Kirin Co.,Ltd. (4151) timely disclosure | Komori